Kratko priopćenje
GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE – HOW TO CHOOSE HYPOGLYCEMIC AGENT?
MAJA BARETIĆ
orcid.org/0000-0002-7242-8407
; Sveučilište u Zagrebu, Medicinski fakultet, Klinika za unutrašnje bolesti, Zavod za endokrinologiju i KBC Zagreb, Zagreb, Hrvatska
VALERIJA BRALIĆ LANG
; Specijalistička ordinacija obiteljske medicine dr. sc. Valerija Bralić Lang, Zagreb, Hrvatska
Sažetak
The management of hyperglycemia in patients with chronic kidney disease (CKD) is complex, and the goals and methods regarding glycemic control are not clearly defined. Although aggressive glycemic control seems to be advantageous in early diabetic nephropathy, outcome data supporting tight glycemic control in patients with advanced CKD are lacking. Challenges in the management of such patients include monitoring diffi culties and the complexity of available treatments. In this article, we review the current treatment options for patients with diabetes and CKD discussing all hypoglycemic agents that currently are available, as well as insulin, along with their indications and contraindications. The aim is to provide useful information to family physicians when deciding on individualized glycemic goals and appropriate therapy for patients with early or end stages of CKD.
Ključne riječi
diabetes mellitus; glycemic control; chronic kidney disease; hypoglycemic agents
Hrčak ID:
179224
URI
Datum izdavanja:
6.4.2017.
Posjeta: 2.620 *